RxDoctor Payments Data

Stephannie Goodrum, APRN

Family · Clinton, KYNPI 1700396405

Payments from drug & device makers

$540in general payments, 2019–2025

Across 39 payments — averaging $13.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$206
  • Lilly USA, LLC$71
  • Baxter Healthcare$47
  • Pfizer$39
  • Novo Nordisk$31
  • Amgen$19
  • plus $126 from 8 others

What the payments were for

  • Food & beverage$540100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$540 in reported general payments places this provider in the 50th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$38,960
Medicare patients
170
Services billed
1,403

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin15$17,779
Repatha SureclickEvolocumab20$15,978
LinzessLinaclotide15$12,439
OzempicSemaglutide12$12,309
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$5,846
Dexlansoprazole DrDexlansoprazole11$1,100
Albuterol Sulfate HfaAlbuterol Sulfate32$774
Losartan Potassium36$699
Omeprazole48$549
Atorvastatin Calcium59$544
Pantoprazole Sodium33$516
Metoprolol Succinate31$508
Oxybutynin Chloride ErOxybutynin Chloride13$506
Amlodipine Besylate51$425
Levothyroxine Sodium44$399

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$206$12,43915 claims
Novo NordiskOzempic$31$12,30912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,374 family providers in Kentucky.

Other family in Clinton

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →